Assessment of Non Vascular Risk Factors for Severity of Diabetic Foot Ulcers (DFUs)
NCT ID: NCT07193992
Last Updated: 2025-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2025-12-01
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factor Analysis for Charcot Foot in Patients With Diabetes Mellitus: The Interplay of Inflammatory Cytokines and Metabolic Factors
NCT07139184
Effects of Pancreaticoduodenectomy on Glucose Metabolism
NCT01388192
Evaluation of the Effect of Type 2 Diabetes Mellitus on the Success of Adult Pulpotomy
NCT07332026
Tissue Changes in Diabetes in Adults and Children Using Multispectral Optoacoustic Tomography.
NCT05935839
A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka
NCT01957592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One of the most serious and costly complications of diabetes is the diabetic foot ulcer (DFU). Globally, the prevalence of DFUs is estimated at around 6.3%, with an annual incidence ranging from 9.1 to 26.1 million cases . This implies that roughly one in sixteen people with diabetes will experience a foot ulcer during their lifetime. DFUs are defined as wounds or ulcerations on the feet of individuals with diabetes, typically resulting from a combination of neuropathy, peripheral artery disease, trauma, and increased plantar pressure . These ulcers may progress to severe complications, including deep infection, osteomyelitis, and lower-limb amputation, leading not only to pain, disability, and psychological distress, but also to increased mortality . Beyond their devastating impact on patients and their families, DFUs pose a significant economic burden on healthcare systems due to high treatment costs and loss of productivity .
To reduce this burden, a clear understanding of the underlying risk factors is critical-not only to treat but also to prevent DFUs. In addition to vascular impairment, non-vascular risk factors have been shown to play a central role in ulcer development, severity, and healing. These include peripheral neuropathy, poor glycemic control, obesity, malnutrition, smoking, repetitive stress and pressure, inadequate foot care, infections such as onychomycosis or tinea pedis, high body mass index, and systemic conditions such as iron-deficiency anemia . Recent studies further emphasized the role of hematologic and nutritional abnormalities (e.g., anemia, hypoalbuminemia , elevated inflammatory markers) as independent predictors of ulcer severity . A systematic assessment of these non-vascular contributors enables clinicians to identify patients at higher risk, tailor treatment strategies, and implement preventive measures at earlier stages. When combined with vascular evaluation, this approach provides a comprehensive risk profile, improves clinical outcomes, reduces the need for amputation. and ultimately enhances quality of life for individuals with diabetes .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Presence of diabetic foot ulcers (DFUs)
* Hemodynamically stable
* Willing and able to provide written informed consent prior to enrollment.
Exclusion Criteria
* Non-diabetic foot ulcers, including venous ulcers or pressure ulcers
* Severe comorbid conditions (e.g., terminal illness or severe cognitive impairment).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shimaa Essam Eldin Rshad Mohammed
Resident Physician, Department of Internal Medicine, Assiut University .
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mona Mohammed Soliman, Professor
Role: STUDY_CHAIR
Assuit university - Endocrinology unit at internal medicine department.
Hanaa Mohammed Riad Hussien, Lecturer
Role: STUDY_DIRECTOR
Assuit university - Endocrinology unit at internal medicine department.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Shimaa EssamEldin Mohammed, Resident doctor at Assiut univ
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Diabetic foot ulcers
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.